| scientific journal | Q5633421 |
| P495 | country of origin | United States of America | Q30 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pediatric pulmonology | Q125416458 |
| P123 | publisher | Wiley | Q1479654 |
| P1476 | title | Pediatric pulmonology. Supplement |
| Q71907970 | 10th Annual North American Cystic Fibrosis Conference. Orlando, Florida, October 24-27, 1996. Abstracts |
| Q73711355 | 11th Annual North American Cystic Fibrosis Conference. Nashville, Tennessee, October 23-26, 1997. Abstracts |
| Q77718567 | 12th Annual North American Cystic Fibrosis Conference. Montreal, Quebec, Canada. October 15-18, 1998. Abstracts |
| Q73051255 | 13th Annual North American Cystic Fibrosis Conference. Seattle, Washington, USA. October 7-10, 1999. Abstracts |
| Q73132662 | 14th Annual North American Cystic Fibrosis Conference. Baltimore, Maryland, USA. November 9-12, 2000. Abstracts |
| Q67890921 | 4th Annual North American and 1990 International Cystic Fibrosis Conference. Arlington, Virginia, October 3-6, 1990. Program and abstracts |
| Q74624876 | 50th Annual North American Cystic Fibrosis Conference. Orlando, Florida, USA. October 25-28, 2001. Abstracts |
| Q67884317 | 6th Annual North American Cystic Fibrosis Conference. Washington, D.C., October 15-18, 1992. Proceedings and Abstracts |
| Q72230733 | 7th Annual North American Cystic Fibrosis Conference. Dallas, Texas, October 13-16, 1993. Abstracts |
| Q72772165 | 8th annual North American Cystic Fibrosis conference. Orlando, Florida, October 20-23, 1994. Abstracts |
| Q79164234 | Abstracts of the 17th annual North American Cystic Fibrosis Conference. Anaheim, California, USA. October 16-19, 2003 |
| Q81198562 | Abstracts of the 19th Annual North American Cystic Fibrosis Conference, Baltimore, Maryland, USA, October 20-23, 2005 |
| Q79169804 | Abstracts of the 20th Annual North American Cystic Fibrosis Conference, November 2-5, 2006, Denver, Colorado, USA |
| Q80868013 | Abstracts of the 21st Annual North American Cystic Fibrosis Conference, October 3-6, 2007, Anaheim, California, USA |
| Q84586563 | Abstracts of the 23rd Annual North American Cystic Fibrosis Conference, Minneapolis, Minnesota, USA, October 15-17, 2009 |
| Q48004783 | Acoustic markers of airway responses during inhalation challenge in children. |
| Q74092827 | Active and passive smoking in adolescence |
| Q41690049 | Acute lower respiratory tract infections in children in the developing world: Kuwait experience |
| Q61943735 | Acute respiratory distress syndrome (ARDS) in children: Multicenter Collaborative Study of the French Group of Pediatric Intensive Care |
| Q41690257 | Acute respiratory infections: epidemiology and treatment |
| Q35695746 | Addressing tobacco smoke exposure: passive and active. |
| Q51700369 | Adherence to asthma therapy: the "blocked receptor". |
| Q33545201 | Advances in management of sleep apnea syndromes in infants and children |
| Q71713875 | Aerosol administration of antibiotics |
| Q74639495 | Aerosol delivery to children: what to use, how to choose |
| Q33545137 | Air pollution and respiratory disease in children: what is the clinically relevant impact? |
| Q48004914 | Airspace fluid clearance in the normal and edematous newborn lung: cardiogenic pulmonary edema fluid alters the clearance of airspace fluid. |
| Q44804509 | Airway inflammation and asthma treatment modalities. |
| Q47929050 | Airway proteins--surfactants. |
| Q79795371 | Airway remodeling: structure and physiology |
| Q41689768 | Allergens and environmental factors in allergic respiratory diseases |
| Q33545184 | Allergic diseases and pediatric allergology in Portugal |
| Q74639568 | Allergy to house dust mite and snails: a model of cross-reaction between food and inhalant allergens with a clinical impact |
| Q74093087 | Anti-inflammatory therapy |
| Q41689814 | Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis |
| Q33545182 | Antibiotic therapy of childhood pneumonia |
| Q41689818 | Antibiotic treatment of Mycoplasma pneumoniae infections. |
| Q79795313 | Antibiotics for asthma? |
| Q48598754 | Apparent Life Threatening Event (ALTE) assessment. |
| Q47929020 | Appropriate use of palivizumb (Synagis). |
| Q41689810 | Are radiological and biological investigations useful for antibiotic treatment of pediatric community acquired pneumonia? |
| Q41690093 | Assessing aerosol delivery system used to treat infants and young children |
| Q71713837 | Assessing nocturnal asthma in children |
| Q47928979 | Assessment of CFTR function in native epithelia for the diagnosis of cystic fibrosis. |
| Q41147866 | Assessment of pancreatic function in screened infants with cystic fibrosis |
| Q48004837 | Assisted cough devices. |
| Q71713854 | Associations and interactions between the esophagus and the lower respiratory tract |
| Q69618820 | Asthma |
| Q74639444 | Asthma epidemiology: clues and puzzles |
| Q79795307 | Asthma guidelines for children--are they useful?--no! |
| Q79795340 | Asthma in developing worlds |
| Q71713801 | BCG policies in Europe |
| Q71713873 | Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia |
| Q74274117 | Behavioral issues in asthma management |
| Q74092920 | Body composition of children with chronic lung disease |
| Q74639454 | Bronchial asthma in children: clinical and epidemiologic approach in different Portuguese speaking countries |
| Q74639451 | Bronchial asthma in infants and children. The German experience |
| Q74092973 | Bronchoalveolar lavage |
| Q33545174 | Bronchoalveolar lavage of newborn infants |
| Q69618826 | Bronchopulmonary dysplasia (BPD) |
| Q41689924 | Bronchoscopy and bronchoalveolar lavage in childhood asthma. When and what for? |
| Q48004942 | Bronchoscopy in critically ill children. |
| Q79795419 | Cath lab assessment |
| Q33545206 | Cellular and molecular mechanisms responsible for the pathogenesis of primary pulmonary hypertension. |
| Q33545169 | Chemokines and chemokine receptors in allergic diseases. |
| Q74639459 | Chest CT-scan in children: main applications and advantages |
| Q71713780 | Chest X-ray in children: use of phosphor plates |
| Q48004887 | Chest wall surgery for asphyxiating thoracic surgery. |
| Q33545163 | Childhood asthma: outcome after 20 years. |
| Q74093133 | Childhood obstructive sleep apnea: diagnostic methods |
| Q41690065 | Childhood tuberculosis and infection with the human immunodeficiency virus. BCG immunization for HIV-seropositive newborns |
| Q41689806 | Chronic lung disease in infants--long-term pulmonary sequelae |
| Q41690053 | Chronic pulmonary sequelae of adenovirus infection. |
| Q44804493 | Classification of phenotypes. |
| Q41689995 | Clinical and pathophysiological aspects of obstructive sleep apnea in children. |
| Q71713851 | Clinical and radiological approach of pulmonary diseases in HIV infection in children |
| Q41690015 | Clinical aspects of neuromuscular diseases |
| Q71713834 | Clinical diagnosis of infant asthma |
| Q41690187 | Clinical indications for lung function tests in infants, children and adolescents. |
| Q71713768 | Clinical lessons from an experimental model of ARDS |
| Q33545181 | Community-acquired pneumonia: diagnosis and treatment. |
| Q74639478 | Compression of the trachea in children |
| Q48004797 | Consequences of snoring and sleep disordered breathing in children. |
| Q34320564 | Controversies and challenges of exercise-induced bronchoconstriction and their implications for children |
| Q33545213 | Corticosteroids and chronic lung disease in extremely immature infants: a dilemma. |
| Q74639472 | Current approach of primary tracheal dyskinesia |
| Q33545165 | Current approaches in tracheal surgery. |
| Q36932517 | Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery |
| Q74092932 | Current recommendations for the resection of pulmonary metastases of pediatric malignancies |
| Q41690056 | Current status of tuberculosis in developing countries. |
| Q43572907 | Current surgical treatment for pleural empyema in children. |
| Q74093140 | Current trends in pediatric tracheotomy |
| Q41690008 | Cystic adenomatoid malformation of the lung. |
| Q69618822 | Cystic fibrosis (CF) |
| Q41690238 | Cystic fibrosis (CF) gene therapy. |
| Q41689853 | Cystic fibrosis: preimplantation diagnosis, prenatal diagnosis and medical ethics, a successful combination |
| Q47929136 | Cytokine cross-talk. |
| Q47929122 | Cytokine therapies. |
| Q41690108 | Cytomegalovirus pneumonitis in children with AIDS. |
| Q47929095 | Defensins & other peptides. |
| Q47929062 | Deficient Na+ channel expression in newborn respiratory distress syndrome. |
| Q41604982 | Definition of pediatric asthma and associated risk factors |
| Q41605040 | Delivery systems: the science. |
| Q57638405 | Demands on spacer devices for young children |
| Q41689749 | Development of sensitization versus tolerance to inhalant allergens during early life |
| Q71713913 | Development of the surfactant system |
| Q41690124 | Developmental aspects of alveolar macrophage functions involved in pulmonary defenses |
| Q45257506 | Developmental aspects of pulmonary defenses in children. |
| Q41690196 | Developmental pathology of the fetal lung |
| Q74639441 | Diagnosis and diagnostic approaches in interstitial lung disease |
| Q41689841 | Diagnosis of pulmonary infections in critically ill immunocompromised children |
| Q71713787 | Diagnostic procedures of GER in childhood lung disease |
| Q41690083 | Diaphragmatic function in severely malnourished patients with anorexia nervosa |
| Q39459235 | Digital radiography of the chest in pediatrics |
| Q44208483 | Directly observed therapy for tuberculosis in children |
| Q41689775 | Discriminant epitopes (EP) in allergy to cow's milk (CM). Characteristics of the immune response and clinical presentation |
| Q41689954 | Disorders of laryngeal mobility in children |
| Q47929032 | Dornase in non-CF. |
| Q41690061 | Drug-resistance in tuberculosis: mechanisms and prevention |
| Q71713845 | Early acquisition of sensitization in childhood asthma |
| Q41690232 | Early asymptomatic pulmonary changes in infants with cystic fibrosis |
| Q41690145 | Early disturbances in cardiorespiratory control |
| Q41690214 | Early inflammation and the development of pulmonary disease in cystic fibrosis |
| Q43407301 | Early interventions in CF. |
| Q36932526 | Early respiratory course in infants with cystic fibrosis: relevance to newborn screening |
| Q74092846 | Early treatment of the atopic child: first results of the clinical trial |
| Q71713808 | Efficacy of BCG immunization against tuberculosis in children |
| Q71713790 | Empiric antibiotic treatment of acute bacterial infections of the lower respiratory tract in children in an era of changing etiology |
| Q41689948 | Endoscopic monitoring of lung transplantation |
| Q41690005 | Endoscopic thoracic surgical treatment of pneumothorax in childhood and adolescence. |
| Q71713885 | Energy balance and nutritional support in cystic fibrosis |
| Q71713848 | Environmental control in childhood asthma |
| Q41690117 | Environmental pollution and asthma |
| Q41689779 | Epidemiology and classification of chronic lung disease. |
| Q41689865 | Epidemiology of allergic disorders in early childhood. |
| Q41689860 | Epidemiology of asthma and allergy in childhood: its impact on offered care in France. |
| Q33545161 | Etiology of CF: knowns and unknowns. |
| Q47928999 | Etiology of sickle cell chest. |
| Q74093122 | Evaluation of BCG and new vaccines against tuberculosis |
| Q41605017 | Evidence for benefits of early intervention with non-steroidal drugs in asthma |
| Q48005001 | Exhaled breath condensate. |
| Q44804486 | Exhaled gas analysis and airway inflammation. |
| Q74093065 | Family dysfunction in asthma: results from a prospective study of the development of childhood atopic illness |
| Q67840073 | Fat-soluble vitamins in infants identified by cystic fibrosis newborn screening |
| Q68312795 | Fifth Annual North American Cystic Fibrosis Conference. Dallas, Texas, October 2-5, 1991. Abstracts |
| Q38856972 | Follow-up of childhood asthma in Morocco |
| Q33545188 | Food allergies in Spain: causal allergens and diagnostic strategies |
| Q71713863 | Food allergy and asthma |
| Q41689878 | From atopic dermatitis to asthma |
| Q41689772 | From atopic dermatitis to asthma: the risk factors and preventive measures. |
| Q71713841 | From pathophysiological mechanisms to pharmacological treatment of childhood asthma |
| Q74093154 | From the chest films to other modalities of imaging |
| Q33545192 | Functional pulmonary surfactant deficiency and neonatal respiratory disorders |
| Q79795499 | Gastroesophageal reflux disease is not a significant cause of lung disease in children |
| Q48004755 | Gastroesophageal reflux is a major cause of lung disease-pro. |
| Q41689800 | General management of chronic lung disease of premature infants |
| Q74092757 | Genetic and environmental determinants in the pathogenesis of allergic diseases |
| Q41690128 | Genetic and environmental determinants of neocortical development |
| Q40909646 | Genetics and bronchial asthma: what is new? |
| Q41604977 | Genetics of asthma: what do we need to know? |
| Q41690161 | Genotype--phenotype correlations: where are we? |
| Q74092860 | Genotype-phenotype relationships in cystic fibrosis patients |
| Q67840075 | Growth evaluation at one year of life in infants with cystic fibrosis diagnosed by neonatal screening |
| Q44804489 | HFA inhalers. |
| Q59738072 | HIV and the lung in developing world |
| Q47929109 | HIV immunology and new therapies |
| Q41690096 | HIV infection in children: what's new in 1996. Place of pulmonary complications. |
| Q30560374 | Health effects of urban outdoor air pollution in children. Current epidemiological data |
| Q71713887 | Heart-lung and bilateral lung transplantation in children with cystic fibrosis |
| Q79795476 | Hemoptysis in children |
| Q46244972 | High frequency chest compression and PEP. |
| Q41689792 | High frequency oscillatory ventilation and the prevention of chronic lung disease |
| Q74092813 | High resolution computed tomography (HRCT) |
| Q41690111 | How do infants and children get sensitized to environmental aeroallergens |
| Q41689978 | How does prone sleeping increase prevalence of sudden infant death syndrome? |
| Q41604996 | How important is quality of life in pediatric asthma? |
| Q33545208 | Imaging of lung vascularization and perfusion in children. |
| Q47929151 | Immune effector cells: mast cells and eosinophils? |
| Q32136180 | Immunoallergic and biologic data supporting strategies for allergen avoidance and immunotherapy |
| Q41690044 | Immunoglobulin subclasses and polysaccharide specific immuno-deficiency states in patients with recurrent respiratory infections |
| Q74639513 | Immunological aspects of bronchopulmonary disease in cystic fibrosis |
| Q71713805 | Immunological aspects of pulmonary tuberculosis in children |
| Q79795294 | Immunotherapy should not be used for asthma |
| Q74639425 | Indoor air pollution and the respiratory health of children |
| Q41689913 | Indoor and outdoor air pollution and childhood asthma |
| Q39130926 | Infant asthma in Tunisia |
| Q41689884 | Infection and pollution |
| Q74092989 | Infection and pollution |
| Q48004934 | Inflammation and airway remodeling. |
| Q41689872 | Inflammation and asthma |
| Q34320559 | Inflammation and remodeling in the adult and child with asthma |
| Q37883664 | Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma |
| Q44804499 | Inhaled antibiotics. |
| Q41689938 | Inhaled corticosteroids in childhood asthma |
| Q41605023 | Inhaled corticosteroids: clinical relevance of safety measures. |
| Q41616534 | Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization |
| Q79795342 | Innate pulmonary immunity: cilia |
| Q33545146 | Interstitial lung disease in children: an overview |
| Q74639547 | Interventional bronchoscopy |
| Q74092980 | Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection |
| Q71713881 | Invasive and noninvasive ventilatory assistance in cystic fibrosis |
| Q45873865 | Ion transport in lung disease. |
| Q67840066 | Is clinical status at diagnosis a prognostic factor in CF infants identified by neonatal screening? |
| Q71713775 | Is there a role for inhaled nitric oxide in pediatric ARDS? |
| Q34320576 | Issues in pediatric asthma |
| Q41171417 | Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin |
| Q74639482 | Laryngotracheal manifestations of gastroesophageal reflux in children |
| Q74639467 | Laryngotracheal stenosis. New perspectives |
| Q33545204 | Larynx and neonatal apneas. |
| Q33545196 | Liquid ventilation: background and clinical trials |
| Q46616476 | Living related donors. |
| Q41689934 | Long acting inhaled beta 2 agonists and inhaled anticholinergic drugs: benefits and side effects in childhood asthma |
| Q48004925 | Long-term follow-up of chronic lung disease of infancy |
| Q33545139 | Lung function testing in infants. |
| Q33545142 | Lung function testing in preschool children. |
| Q41690075 | Lung growth and development during experimental malnutrition. |
| Q44364985 | Lung injury in utero and neonatal pulmonary emphysema |
| Q41690077 | Malnutrition, renutrition and respiratory function |
| Q71713860 | Management of GER in childhood asthma |
| Q73967557 | Management of Pediatric Asthma. Symposium proceedings. London, England, November 18, 1996 |
| Q41689826 | Management of acute dyspnea in children |
| Q74639487 | Management of chronic sinusitis in children with cystic fibrosis |
| Q73745420 | Management of pediatric asthma |
| Q41605033 | Managing symptoms and exacerbations in pediatric asthma |
| Q48005014 | Manchester cohort |
| Q44804490 | Matching the device to the patient. |
| Q41690134 | Maturation of brainstem respiratory neuronal networks. |
| Q74093116 | Measles immunization policies and control in Europe |
| Q40405638 | Mechanical ventilation of children with the adult respiratory distress syndrome. |
| Q41616526 | Mechanisms of hypersecretion in acute asthma, proposed cause of death, and novel therapy |
| Q53900502 | Mechanisms of steroid resistance in asthma. |
| Q74639463 | Mediastinal and thoracic MRI in children |
| Q41689758 | Mediators and cytokines in allergic disease. |
| Q33545167 | Mixed viral-bacterial pulmonary infections in children |
| Q35695731 | Modifier genes in cystic fibrosis |
| Q71713866 | Molecular biology of cystic fibrosis: state of the art |
| Q48004903 | Monitoring and assessment of acute lung injury. |
| Q34320570 | Montelukast in 2- to 5-year-old children with asthma. |
| Q71713793 | Mortality during acute bacterial infections of the lower respiratory tract in children |
| Q41689753 | Mother-infant interactions during fetal and neonatal life with special reference to atopy. |
| Q79795348 | Mucomodulator therapy in cystic fibrosis: balancing mucus clearability against the spread of airborne pathogens |
| Q40405645 | Mycobacterium avium intracellulare infection in children with AIDS. |
| Q74093128 | Nasal polyposis in children |
| Q71713824 | Natural history of childhood asthma |
| Q74093003 | Neonatal hypoxia disturbs the catecholamine turnover in the nucleus of the tractus solitarius and the peripheral chemoreceptors of the adult rat |
| Q53900496 | Neonatal pulmonary hypertension: a physiologic approach to treatment. |
| Q41689906 | Neural mechanisms in asthma: new developments |
| Q74093046 | Neurodevelopmental follow-up of children after severe neonatal asphyxia |
| Q33545211 | New developments in the pathogenesis and treatment of neonatal pulmonary hypertension. |
| Q33545199 | New modes of ventilation: a non-aggression pact |
| Q44804506 | New therapies for pulmonary hypertension in neonates and children. |
| Q33545194 | New tools in ventilatory support: high frequency ventilation, nitric oxide, tracheal gas insufflation, non-invasive ventilation. |
| Q44804503 | New treatments for pediatric sinusitis |
| Q68331419 | Newborn screening for cystic fibrosis. Proceedings from IVth International Conference, October 8-9, 1990, Colorado, USA |
| Q67840077 | Newborn screening for cystic fibrosis: a historical perspective |
| Q71713763 | Nitric oxide inhalation |
| Q79795356 | Non-genetic influences on CF lung disease: the role of sociodemographic characteristics, environmental exposures and healthcare interventions |
| Q33545153 | Non-invasive biomarkers of asthma. |
| Q48004814 | Non-invasive ventilation in preterm infants |
| Q35695738 | Non-pulmonary therapy in the NICU. |
| Q36679748 | Nonantibiotic inhaled therapy in cystic fibrosis: new data. |
| Q71713822 | Nontuberculous pulmonary infections in pediatric AIDS |
| Q41689943 | Normal values of bronchoalveolar lavage. |
| Q69407723 | North American Cystic Fibrosis Conference. Toronto, Ontario, Canada. October 14-17, 1987. Abstracts |
| Q41690084 | Nutrition and development of pulmonary defense mechanisms |
| Q44951010 | Nutritional assessment of infants with cystic fibrosis diagnosed through screening |
| Q71713818 | Older and newer challenges of tuberculosis in children |
| Q41689743 | Ontogeny of the immune system with special reference to IgE. |
| Q58143881 | Optimal oxygen therapy in the newborn period |
| Q41690155 | Organization of home care for patients with cystic fibrosis |
| Q34320546 | Origins and treatment of airway inflammation in childhood asthma |
| Q42738933 | Outcome after Liver Transplantation for Cystic Fibrosis. |
| Q79795522 | Outdoor air pollution and asthma |
| Q41605048 | Overview of delivery system issues in pediatric asthma |
| Q41690088 | Oxygen consumption in infants with bronchopulmonary dysplasia |
| Q51163965 | Parental attitudes toward newborn screening for cystic fibrosis. |
| Q74093052 | Parental representations of preterm infants with a respiratory distress syndrome |
| Q39489921 | Parietaria allergy in children. |
| Q57133043 | Particularities of pollen allergies in Greece |
| Q41689990 | Pathology of SIDS and new understandings |
| Q71713857 | Pathophysiology and mechanisms of gastroesophageal reflux in childhood asthma |
| Q41690020 | Pathophysiology of the respiratory consequences of childhood neuromuscular disorders |
| Q71713918 | Patient-triggered ventilation |
| Q74639574 | Peanut hypersensitivity in children |
| Q52933397 | Pediatric asthma: "Real world" measures of effectiveness. |
| Q40820246 | Pediatric bronchoscopy in the 21st century: challenges and opportunities. |
| Q71713761 | Penicillin-resistant Streptococcus pneumoniae and acute pulmonary infections: prevalence and severity |
| Q74093109 | Pertussis immunization: results of new trials |
| Q71713895 | Pertussis: the new acellular vaccines |
| Q41690141 | Pharmacology of respiratory control in neonates and children |
| Q74092938 | Place of surgery in malignant mediastinal tumors in children |
| Q41690103 | Pneumocystosis in infants and children with HIV: current concepts |
| Q44804496 | Post-Infectious Bronchiolitis Obliterans. |
| Q79795398 | Post-transplant complications |
| Q41690190 | Postnatal lung development and its impairment by glucocorticoids |
| Q41690149 | Practical strategy for the diagnosis of food allergies |
| Q74093022 | Practice of non invasive pulmonary function testing in ventilated neonates and spontaneously breathing infants |
| Q41689968 | Pregnancy in patients with cystic fibrosis |
| Q41690138 | Prenatal development of the central catecholaminergic neurons in human embryos and fetuses |
| Q56241323 | Prenatal diagnosis of cystic fibrosis |
| Q79795505 | Prenatal influences on the development of allergy and asthma TH1/TH2 balance |
| Q74093011 | Prescription of child respiratory physiotherapy |
| Q41689856 | Present methods for diagnosis of lower respiratory tract infections in Lebanon |
| Q74092784 | Prevention of chronic lung disease (CLD) in premature infants with early dexamethasone therapy |
| Q79795384 | Prevention of sudden infant death syndrome |
| Q51700360 | Prevention strategies of chronic lung disease. |
| Q41689764 | Primary and secondary prevention of allergic sensitization. |
| Q74092944 | Primary bronchopulmonary tumors in children |
| Q41689822 | Primitive neonatal pulmonary infections: diagnosis and treatment |
| Q80022167 | Proceedings of the Sixth International Congress on Pediatric Pulmonology. February 28-March 2, 2004. Lisbon, Portugal |
| Q43600228 | Profile of the asthmatic child in Lebanon |
| Q68057117 | Program and papers: 2nd annual North American Cystic Fibrosis Conference. Orlando, Florida, September 28-October 1, 1988. Abstracts |
| Q45788989 | Progress toward the development of a respiratory syncytial virus vaccine |
| Q41690242 | Prospects for a parainfluenza virus vaccine |
| Q41690207 | Psychiatric aspects of severe chronic asthma in infants, children and adolescents |
| Q51107197 | Psychological adjustment of children and adolescents with cystic fibrosis. |
| Q51163964 | Psychological impact of false-positive results when screening for cystic fibrosis. |
| Q41690262 | Psychological management in the asthmatic adolescent. |
| Q41689973 | Psychosocial aspects for the management of adults with cystic fibrosis |
| Q74639501 | Pulmonary arteriovenous shunting and pulmonary artery hypertension in children with liver disease |
| Q41689845 | Pulmonary aspergillosis in immunocompromised children. |
| Q79795327 | Pulmonary complications of HIV |
| Q43804388 | Pulmonary complications of neuromuscular disease |
| Q79795541 | Pulmonary diagnostic procedures: bronchoscopy |
| Q41689782 | Pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia |
| Q41690000 | Pulmonary malformations: developmental and pathological features |
| Q74092774 | Pulmonary manifestations of food allergy in children |
| Q74639507 | Pulmonary manifestations of rheumatic diseases |
| Q79795546 | Pulmonary scintigraphy in chronic obstructive pulmonary disease |
| Q74092806 | Pulmonary sequelae of prematurity: radiological manifestations |
| Q74092877 | Pulmonary sequestrations |
| Q53607574 | Pulmonary transplantation and psychopathology. |
| Q41690091 | Rationale for spacer use in children. |
| Q41690038 | Recurrent respiratory infections in children: a practical approach for clinical work |
| Q33545151 | Regional differences in prevalence and risks of respiratory diseases in children |
| Q41689895 | Relation between environment and recurring upper-airway infections in children |
| Q71713870 | Relationships between gene mutations and clinical features in cystic fibrosis |
| Q41690025 | Respiratory concerns in Duchenne muscular dystrophy (DMD). |
| Q33545144 | Respiratory function testing in early childhood: where have we come from and where are we going? |
| Q36932522 | Respiratory physiological measurements in infants with cystic fibrosis. |
| Q74092892 | Respiratory problems in congenital myopathies |
| Q41690032 | Respiratory problems in spinal muscular atrophies |
| Q71713797 | Resurgence of tuberculosis in children |
| Q44760264 | Risk factors for airway hyperresponsiveness in childhood asthma |
| Q38873363 | Risk factors of the asthmatic child living in a humid tropical environment |
| Q41690174 | Risk reduction of injury or death from tracheobronchial foreign bodies in children. |
| Q33545148 | Role of allergens in the natural history of childhood asthma |
| Q38984630 | Role of allergic factors in childhood asthma in Morocco |
| Q41689892 | Role of bacterial infections in children with asthma |
| Q71713831 | Role of eosinophils in childhood asthma inflammation |
| Q74639525 | Role of neutral endopeptidase and angiotensin converting enzyme in asthma |
| Q44645275 | Screening for cystic fibrosis: why, how, and when? |
| Q74304166 | Second International Congress on Pediatric Pulmonology. Nice, France, June 2-5, 1996. Proceeding and abstracts |
| Q48004956 | Severe acute respiratory syndrome (SARS) in children |
| Q41690167 | Severe laryngeal manifestations of gastroesophageal reflux in children |
| Q74093146 | Severe laryngomalacia: surgical indications and results |
| Q79795492 | Sickle cell disease: pulmonary management options |
| Q48004731 | Sleep polygraphic studies in children: indications and techniques |
| Q48004791 | Snoring in children: still many questions, only a few answers. |
| Q48598727 | Snoring: investigations guidelines |
| Q33545190 | Specific childhood allergic diseases in southern Europe: synthesis and conclusions. |
| Q44240708 | Staphylococcus aureus in cystic fibrosis: implications for prognosis and treatment |
| Q33545215 | Strategy for the prevention and treatment of chronic lung disease of the premature infant. |
| Q47929008 | Surfactant protein B deficiency as a prototype. |
| Q61607298 | Surfactant replacement therapy |
| Q41690201 | Survivors of neonatal congenital lung diseases: pulmonary follow-up |
| Q53351053 | TB and IUATLD. |
| Q71713765 | Target diseases for the newly developed technology in respiratory care |
| Q80861498 | The 18th Annual North American Cystic Fibrosis Conference. St. Louis, Missouri, USA, October 14-17, 2004. Proceedings and abstracts |
| Q71713759 | The 1st International Congress on Pediatric Pulmonology. Nice, France, June 2-5, 1994 |
| Q71785261 | The 9th annual North American Cystic Fibrosis Conference. Dallas, Texas, October 12-15, 1995. Abstracts |
| Q67840060 | The application of PCR amplification and the polymorphic marker KM.19 to dried blood spots: comparison with deletion 508 for the confirmation of the neonatal screening test for cystic fibrosis |
| Q47929162 | The biology of T-cells in allergy and asthma: beyond the TH1/TH2 concept. |
| Q41604988 | The burden of pediatric asthma |
| Q41689986 | The changing epidemiology of SIDS following the national risk reduction campaigns |
| Q41690220 | The clinical use of rhDNAse |
| Q47929081 | The delivery of proteins and peptides to the lung |
| Q41690183 | The high speed interrupter technique (HIT) and its role in wheezing disorders in infants |
| Q33545177 | The immune responses in tuberculosis: role for pathogenesis, diagnosis and prevention |
| Q41690179 | The impulse oscillation technique applied for measurements of respiratory function in young children |
| Q44536980 | The international quality assurance program (IRTIQAS) for the assay of immunoreactive trypsin in dried blood spots |
| Q41689899 | The place of antibiotics in pediatric upper respiratory tract infections |
| Q33545155 | The recent evolution of pulmonary imaging in the fetus and neonate |
| Q41689910 | The relationship between impaired lung growth and onset of bronchial asthma in early life |
| Q51616833 | The risk of anesthesia in the asthmatic child. |
| Q74093073 | The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers |
| Q57138321 | The role of allergen avoidance in primary and secondary prevention |
| Q35695754 | The role of allergen exposure and sensitization |
| Q41689787 | The role of cytokines in the development of pulmonary fibrosis in preterm infants |
| Q79795515 | The role of early infections, hygiene and intestinal microflora |
| Q79795518 | The role of passive smoking and indoor pollution |
| Q28372197 | The role of pulmonary inflammation in the development of pulmonary hypertension in newborn with meconium aspiration syndrome (MAS) |
| Q33545179 | The role of viral and atypical bacterial pathogens in asthma pathogenesis |
| Q48828664 | The use of nasal CPAP in children. |
| Q71713812 | The value of flexible bronchoscopy in childhood pulmonary tuberculosis |
| Q33545158 | Therapeutic strategies for treatment of CF based on knowledge of CFTR. |
| Q33545171 | Therapy of allergic pulmonary diseases with anti-IgE antibodies. A review. |
| Q48828686 | There's no place like home: evaluation of obstructive sleep apnea in the child's home. |
| Q69708108 | Third annual North American Cystic Fibrosis Conference. Tarpon Springs, Florida, October 11-14, 1989. Abstracts |
| Q71713784 | Thoracic helical CT in pediatric patients |
| Q41689961 | Tolerance of bronchoscopy in extreme clinical situations |
| Q57638332 | Towards improved aerosol devices for the young child |
| Q40524013 | Training pediatric pulmonologists for the future: academic is a state of mind not just a location. |
| Q39133914 | Treatment of childhood asthma in Algeria. |
| Q71713816 | Treatment of pulmonary tuberculosis in children: new trends |
| Q46089786 | Treatment of severe asthma in childhood |
| Q48004982 | Treatment options of asthma in infancy |
| Q41690068 | Tuberculin--which test is best? |
| Q74639555 | Tuberculosis in children: where do we go now? |
| Q39622866 | Tuberculosis in the developing world. |
| Q41690071 | Tuberculosis: new tools for diagnosis |
| Q48004741 | Tuberculosis: role of etiologic diagnosis and tuberculin skin test |
| Q74093060 | Understanding and managing poor adherence in cystic fibrosis |
| Q71713828 | Update in allergy testing in childhood asthma: how do you know whether you are successfully controlling the patient's inflammation? |
| Q41690226 | Use of bronchodilator therapy in cystic fibrosis. |
| Q41605009 | Use of inhaled corticosteroids in pediatric asthma |
| Q41689837 | Usefulness of ultrasonography (US) in the diagnosis of a mediastinal opacity |
| Q74093079 | Vaccinations against Pseudomonas aeruginosa: active and passive alternatives |
| Q48004895 | Ventilation techniques including liquid ventilation. |
| Q51550720 | Video surgical technique for interruption of patent ductus arteriosus in children and neonates. |
| Q74092925 | Video-assisted thoracoscopic surgery for bronchiectasies |
| Q41605003 | What are the goals of treating pediatric asthma? |
| Q47928987 | What causes allergy and asthma? Early postnatal influences. |
| Q79795525 | What causes allergy and asthma? The role of dietary factors |
| Q41689929 | What must we treat in childhood asthma: symptoms and/or abnormal function? |
| Q41689918 | Wheezing in infancy: when is it asthma? |
| Q48004920 | When should children be referred for lung or heart-lung transplantation? |
| Q48828678 | Why should infants with sleep apneas and apparent life-threatening events be recorded polygraphically? |
Search more.